. may 16, 2018
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Walles-grandpa-of-Grainey-from-La-Purisima?Looneyfat=131
.
(soundbite of les pommes de ma douche's "trompettes de la renommee") transcript provided by npr, copyright npr.
.ai-based software may help predict risk of dementia
.